Highlights and Quick Summary
- Common Equity (Total) for the quarter ending February 28, 2022 was $404 Million (a 7.2% increase compared to previous quarter)
- Year-over-year quarterly Common Equity (Total) decreased by -2.79%
- Annual Common Equity (Total) for 2021 was $381 Million (a 66.54% increase from previous year)
- Annual Common Equity (Total) for 2020 was $229 Million (a -7.0% decrease from previous year)
- Annual Common Equity (Total) for 2019 was $246 Million (a 73.15% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Equity (Total) of Organigram Holdings Inc.
Most recent Common Equity (Total)of OGI including historical data for past 10 years.Interactive Chart of Common Equity (Total) of Organigram Holdings Inc.
Organigram Holdings Inc. Common Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $404.24 | – | – | – | – |
| 2021 | $377.1 | $380.8 | $415.85 | $212.09 | $380.8 |
| 2020 | $242.02 | $222.82 | $229.11 | $287.02 | $228.65 |
| 2019 | $248.72 | $246.66 | $250.94 | $207.8 | $245.87 |
| 2018 | – | – | $178.08 | $144.56 | $142.0 |
| 2017 | – | – | – | – | $65.38 |
| 2016 | – | – | – | – | $33.79 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic